Goldman, Michel
Seigneuret, Nathalie
Eichler, Hans-Georg
Article History
First Online: 12 December 2014
Competing interests
: Michel Goldman and Nathalie Seigneuret are appointed by the Innovative Medicines Initiative (IMI). Hans-Georg Eichler is a member of the IMI Scientific Committee and is appointed by the European Medicines Agency, which is a partner of some IMI consortia.